MedTrace Logo

Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform

NCT04369833 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2022-05-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to collect a variety of clinical data and blood glucose changes using a continuous glucose monitoring device for high-risk diabetes patients (prediabetes) in order to develop a personalized diabetes prevention and management platform based on artificial intelligence model using mathematical analysis.

Conditions

Interventions

DEVICE

continuous glucose monitoring system

wearing continuous glucose monitoring device (iPro2 professional continuous glucose monitoring, MedtronicⓇ, California, USA)

Sponsors & Collaborators

  • Pusan National University Hospital

    lead OTHER

Principal Investigators

  • Sang soo Kim, Master · Pusan National University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-11
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04369833 on ClinicalTrials.gov